window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

European biotech

  • European biotech,Genomics and sequencing,Medical devices,Partnerships & Funding,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    Lithuania sets stage for Life Sciences Baltics with multi-billion-euro investments and AI innovation

    Lithuania’s life sciences sector is preparing to showcase its rapid [...]

    September 15, 2025
  • Chronic diseases,Drug Development,European biotech,Pharmaceuticals and therapeutics

    MRM Health raises €55 million to advance microbiome-based therapies for ulcerative colitis and beyond

    MRM Health, a clinical stage biopharmaceutical company developing microbiome-based therapeutics, [...]

    September 9, 2025
  • Clinical Trials,Drug Development,European biotech,Precision medicine

    DeuterOncology presents phase 1 data for do-2 MET inhibitor showing tumour control with low side effects

    DeuterOncology, a clinical-stage biotech company developing deuterated cancer therapies, has [...]

    September 10, 2025
  • Cell & Gene Therapy,Clinical Development,Clinical Trials,European biotech,Partnerships & Funding,Patient Centricity

    Anocca raises SEK 440M to advance TCR-T cell therapies into clinical development

    Swedish clinical-stage biotech Anocca AB has secured approximately SEK 440 [...]

    August 19, 2025
  • Cell & Gene Therapy,European biotech,Movers & Shakers

    Atelerix appoints new chair and non-executive director to board

    Atelerix, a Newcastle-based biotech specialising in hydrogel encapsulation for cell [...]

    August 12, 2025
  • Chronic diseases,Clinical Trials,Drug Development,European biotech,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    InflaRx targets key data readouts for INF904 in skin conditions

    InflaRx has reported its Q2 2025 results and provided updates [...]

    August 11, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Data Management,European biotech,Research & Development

    Labguru and Titian Software rebrand as Cenevo to accelerate scientific discovery

    Labguru and Titian Software have rebranded under a unified identity, [...]

    July 31, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Development,European biotech,Partnerships & Funding,Supply Chain & Logistics

    Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden

    Acquisition enhances innovation offering and expands biotech footprint across Nordic [...]

    July 29, 2025
  • Clinical Trials,European biotech,Oncology,Partnerships & Funding,Precision medicine,Research & Development

    MaaT Pharma lands €37.5M EIB loan to boost microbiome cancer pipeline

    Tranche-based debt financing will support EMA review of Xervyteg and [...]

    July 28, 2025
  • Biologics & Biosimilars,Drug Development,European biotech,Partnerships & Funding,Precision medicine,Technology and platforms

    Kling Bio and Sanofi collaborate to accelerate discovery of next-generation antiviral antibodies

    Biotech company Kling Bio has announced a new collaboration with [...]

    July 24, 2025
Previous456Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top